Amneal Pharmaceuticals Inc's Comment on Supply Chain
The company sources raw materials, including active pharmaceutical ingredients (APIs), from various manufacturers and distributors of bulk pharmaceutical chemicals, and manufactures certain APIs at its facilities in India. Some raw materials are sourced from single suppliers, with only one supplier typically listed in FDA product applications. Qualifying a new sole-source supplier generally takes 24 to 30 months. To mitigate supply risks, the company usually maintains two or more suppliers where feasible and may contract with raw material distributors. Manufacturing operations are located in the U.S., India, and Ireland, supported by a distribution center in Glasgow, Kentucky. For the year ended December 31, 2025, 46% of net revenue from Affordable Medicines was generated from U.S. facilities, 24% from India, and approximately 30% from third-party manufacturers. Specialty products are produced both internally and by third parties. The AvKARE segment operates distribution centers in Fountain Run, Kentucky; Glasgow, Kentucky; and Philadelphia, Pennsylvania.
Amneal Pharmaceuticals Inc's Comment on Supply Chain
The company sources raw materials, including active pharmaceutical ingredients (APIs), from various manufacturers and distributors of bulk pharmaceutical chemicals, and manufactures certain APIs at its facilities in India. Some raw materials are sourced from single suppliers, with only one supplier typically listed in FDA product applications. Qualifying a new sole-source supplier generally takes 24 to 30 months. To mitigate supply risks, the company usually maintains two or more suppliers where feasible and may contract with raw material distributors. Manufacturing operations are located in the U.S., India, and Ireland, supported by a distribution center in Glasgow, Kentucky. For the year ended December 31, 2025, 46% of net revenue from Affordable Medicines was generated from U.S. facilities, 24% from India, and approximately 30% from third-party manufacturers. Specialty products are produced both internally and by third parties. The AvKARE segment operates distribution centers in Fountain Run, Kentucky; Glasgow, Kentucky; and Philadelphia, Pennsylvania.
Sources:
Amneal Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Amneal Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
